Validation of a Novel Diagnostic, Prognostic Assay for Bacterial Vaginosis
NCT02185456
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Bacterial Vaginosis
Interventions
DRUG:
750 mg metronidazole/ 200 mg miconazole vaginal suppository
DRUG:
Standard of care
Sponsor
Wayne State University
Collaborators
[object Object]